Ciguatera fish poisoning in France: experience of the French Poison Control Centre Network from 2012 to 2019.


Journal

Clinical toxicology (Philadelphia, Pa.)
ISSN: 1556-9519
Titre abrégé: Clin Toxicol (Phila)
Pays: England
ID NLM: 101241654

Informations de publication

Date de publication:
Mar 2021
Historique:
pubmed: 8 7 2020
medline: 18 8 2021
entrez: 8 7 2020
Statut: ppublish

Résumé

Ciguatera fish poisoning (CFP) is a common Poisoning in the tropical countries. France is directly concerned with French tourists in endemic area and with French citizens living in the French overseas territories. Retrospective, descriptive study of CFP cases handled by the French Poison Control Centre Network from 2012 through 2019. Fifty-two events were studied concerning 130 patients. The fish species was identified for 41 events, mainly belonging to five fish families: 14 groupers, 11 snappers, 5 jacks, 4 parrotfishes, 4 barracudas. The origin of the fish was the Atlantic Ocean (23 events), the Indian Ocean (17 events) and the Pacific Ocean (12 events). 91% of the poisonings occurring in the Atlantic Ocean began with gastrointestinal effects while in 44% of events occurring in the Pacific Ocean, the patients had no gastrointestinal effects (onset with neurological symptoms: paraesthesia and dysesthesia). The evolution of the 130 patients has been classic for CFP with persistent symptoms during 1 to 45 weeks. Numerous patients reported exacerbation of neurological signs several months after poisoning following consumption of alcoholic beverages (23 patients) or seafood (19 patients). Medical practitioners in Europe must be trained to manage CFP as cases are reported with tourists returning from endemic areas but also with poisoned patients far from tropical areas after consumption of imported fish.

Identifiants

pubmed: 32633146
doi: 10.1080/15563650.2020.1788052
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

252-255

Auteurs

Luc de Haro (L)

Clinical Pharmacology and Poison Control Centre, APHM, Hôpital Sainte Marguerite, Marseille, France.

Corinne Schmitt (C)

Clinical Pharmacology and Poison Control Centre, APHM, Hôpital Sainte Marguerite, Marseille, France.

Sandra Sinno-Tellier (S)

French Agency for Food, Environmental and Occupational Health & Safety, Maisons Alfort, France.

Nathalie Paret (N)

Poison Control Centre, HCL, Lyon, France.

David Boels (D)

Pharmacology and Toxicology Department, Nantes University Hospital, Nantes, France.
Inserm UMRS1144, University of Paris, Paris, France.

Gaël Le Roux (G)

Poison Control Centre, Angers, France.

Jérôme Langrand (J)

Poison Control Centre, APHP, Paris, France.

Nicolas Delcourt (N)

Poison Control Centre & Inserm UMRS1214, Toulouse University Hospital, Toulouse, France.

Magali Labadie (M)

Poison Control Centre, Bordeaux, France.

Nicolas Simon (N)

Clinical Pharmacology and Poison Control Centre, Université, APHM, INSERM, IRD, SESSTIM, Hôpital Sainte Marguerite, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH